Eurofins Scientific SE Asset Resilience Ratio

Latest as of December 2025: 7.20%

Eurofins Scientific SE asset resilience ratio. Eurofins Scientific SE (ERF) has an Asset Resilience Ratio of 7.20% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Eurofins Scientific SE to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€791.00 Million
≈ $924.76 Million USD Cash + Short-term Investments

Total Assets

€10.98 Billion
≈ $12.84 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Eurofins Scientific SE (2004–2025)

Asset resilience ratio of Eurofins Scientific SE from 2004 to 2025. This chart shows how Eurofins Scientific SE's Asset Resilience Ratio has changed over time. Read ERF total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Eurofins Scientific SE's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Eurofins Scientific SE asset portfolio.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €791.00 Million 7.2%
Short-term Investments €0.00 0%
Total Liquid Assets €791.00 Million 7.20%

Asset Resilience Insights

  • Limited Liquidity: Eurofins Scientific SE maintains only 7.20% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Eurofins Scientific SE Industry Peers by Asset Resilience Ratio

Compare Eurofins Scientific SE's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Revvity Inc.
NYSE:RVTY
Diagnostics & Research 0.00%
Wuhan Thalys Med Tech Co Ltd
SHG:603716
Diagnostics & Research 0.16%
JOONGANG DNM Co.Ltd
KQ:051980
Diagnostics & Research 27.26%
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193
Diagnostics & Research 70.50%
Krsnaa Diagnostics Limited
NSE:KRSNAA
Diagnostics & Research 9.90%
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%
Australian Clinical Labs Ltd
AU:ACL
Diagnostics & Research 4.11%

Eurofins Scientific SE Asset Resilience Ratio by Year (2004–2025)

Eurofins Scientific SE asset resilience ratio by year from 2004 to 2025. The table below shows the annual Asset Resilience Ratio data for Eurofins Scientific SE.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 2.29% €251.60 Million
≈ $294.15 Million
€10.98 Billion
≈ $12.84 Billion
+1.53pp
2024-12-31 0.77% €83.30 Million
≈ $97.39 Million
€10.89 Billion
≈ $12.73 Billion
-3.61pp
2023-12-31 4.38% €476.40 Million
≈ $556.96 Million
€10.89 Billion
≈ $12.73 Billion
+3.30pp
2022-12-31 1.08% €108.80 Million
≈ $127.20 Million
€10.08 Billion
≈ $11.79 Billion
+0.71pp
2021-12-31 0.37% €34.80 Million
≈ $40.68 Million
€9.33 Billion
≈ $10.91 Billion
+0.17pp
2020-12-31 0.20% €17.40 Million
≈ $20.34 Million
€8.58 Billion
≈ $10.03 Billion
+0.16pp
2019-12-31 0.05% €3.60 Million
≈ $4.21 Million
€7.82 Billion
≈ $9.15 Billion
-0.30pp
2018-12-31 0.34% €24.60 Million
≈ $28.76 Million
€7.21 Billion
≈ $8.42 Billion
-2.29pp
2017-12-31 2.63% €153.29 Million
≈ $179.22 Million
€5.83 Billion
≈ $6.82 Billion
-9.63pp
2016-12-31 12.25% €506.02 Million
≈ $591.59 Million
€4.13 Billion
≈ $4.83 Billion
-3.72pp
2015-12-31 15.98% €591.10 Million
≈ $691.06 Million
€3.70 Billion
≈ $4.33 Billion
+12.04pp
2014-12-31 3.94% €73.83 Million
≈ $86.31 Million
€1.87 Billion
≈ $2.19 Billion
-8.19pp
2013-12-31 12.13% €181.62 Million
≈ $212.34 Million
€1.50 Billion
≈ $1.75 Billion
+11.18pp
2012-12-31 0.95% €11.02 Million
≈ $12.88 Million
€1.16 Billion
≈ $1.36 Billion
+2.04pp
2007-12-31 -1.09% €-6.67 Million
≈ $-7.80 Million
€612.02 Million
≈ $715.52 Million
+0.20pp
2006-12-31 -1.29% €-5.93 Million
≈ $-6.94 Million
€460.34 Million
≈ $538.18 Million
-1.10pp
2004-12-31 -0.18% €-351.00K
≈ $-410.36K
€190.12 Million
≈ $222.28 Million
--
pp = percentage points

About Eurofins Scientific SE

PA:ERF France Diagnostics & Research
Market Cap
$18.10 Billion
€15.49 Billion EUR
Market Cap Rank
#2126 Global
#46 in France
Share Price
€88.64
Change (1 day)
-0.45%
52-Week Range
€56.74 - €89.04
All Time High
€121.25
About

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more